PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
2018 · Journal of Clinical Investigation · 147 citations
https://doi.org/10.1172/jci98047
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
1.6K
Citations
11
h-index
12
i10-index
Jacob Ricca is an academic researcher from Cornell University. The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses. The author has an h-index of 11, co-authored 23 publications.
ORCID: 0000-0002-5649-4041Click to start Chat